Sensus Healthcare Expands Role of President Michael Sardano to Include Chief Commercial Officer
New responsibilities recognize Mr. Sardano’s significant accomplishments in securing CPT® codes for office-based SRT and the growing commercial opportunity the Company now faces BOCA RATON, Fla. – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, today announced that President […]
Sensus Healthcare Appoints Eric Sachetta to its Board of Directors
Seasoned financial executive brings leadership acumen, strategic growth expertise and a strong track record of operational excellence BOCA RATON, Fla. – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, today announced the appointment of Eric Sachetta to the Company’s […]
Treatment for Uncommon Skin Cancer Locations
When most people think of skin cancer, they imagine sun-damaged areas like the face, shoulders, or arms, but there are uncommon skin cancer locations that are often overlooked. Even when the summer is over, skin cancer is a year-round concern for all nooks and crannies of your body. Early detection is critical, and understanding the […]
Shifting the Standard: Why Non-Invasive Skin Cancer Treatments Are the Future of Skin Cancer Therapy
As October is Breast Cancer Awareness Month, a time dedicated to education, early detection, and advancing treatments that prioritize survival and quality of life, we are reminded how non-invasive skin cancer treatment is important in working towards the same goals of helping patients find treatment options that work for their unique lifestyles. This month provides […]
Sensus Healthcare Reports Third Quarter 2025 Financial Results
Centers for Medicare & Medicaid Services (CMS) established coding validating superficial radiotherapy (SRT) for treating non-melanoma skin cancer Revenues of $6.9 million Shipped 16 SRT systems including three to China Fair Deal Agreement (FDA) treatment volume increased 20% over the second quarter Exited the quarter with $24.5 million in cash and no debt Conference call […]
Sensus Healthcare Named to TIME’s America’s Growth Leaders of 2026
Recognition in top 100 of this inaugural ranking of 500 companies reflects five-year growth performance, financial stability and stock performance BOCA RATON, Fla. – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, today announced that it has been named […]
CMS Establishes Coding Validating Sensus SRT for Treating Non-Melanoma Skin Cancer
First-ever dedicated Current Procedural Terminology (CPT®) codes represent compelling economics and reimbursement certainty BOCA RATON, Fla. – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, announces that the Centers for Medicare & Medicaid Services (CMS) has published a distinct […]
